Market closed
CalciMedica Inc./$CALC
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About CalciMedica Inc.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.
Ticker
$CALC
Sector
Trading on
Industry
Pharmaceuticals
Headquarters
Employees
14
Website
CalciMedica Inc. Metrics
BasicAdvanced
$21M
-
-$1.22
1.11
-
Price and volume
Market cap
$21M
Beta
1.11
52-week high
$2.45
52-week low
$1.45
Average daily volume
46K
Financial strength
Current ratio
5.338
Quick ratio
5.068
Management effectiveness
Return on assets (TTM)
-94.61%
Return on equity (TTM)
-121.42%
Valuation
Price to book
1.45
Price to tangible book (TTM)
1.45
Price to free cash flow (TTM)
-0.824
Growth
Earnings per share change (TTM)
-84.09%
3-year earnings per share growth (CAGR)
-47.98%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for CalciMedica Inc. stock?
CalciMedica Inc. (CALC) has a market cap of $21M as of April 20, 2025.
What is the P/E ratio for CalciMedica Inc. stock?
The price to earnings (P/E) ratio for CalciMedica Inc. (CALC) stock is 0 as of April 20, 2025.
Does CalciMedica Inc. stock pay dividends?
No, CalciMedica Inc. (CALC) stock does not pay dividends to its shareholders as of April 20, 2025.
When is the next CalciMedica Inc. dividend payment date?
CalciMedica Inc. (CALC) stock does not pay dividends to its shareholders.
What is the beta indicator for CalciMedica Inc.?
CalciMedica Inc. (CALC) has a beta rating of 1.11. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.